Niktimvo

Axatilimab-csfr · Incyte Corporation
PRESCRIPTION ONLY (USA)

Niktimvo ingredients

Active ingredientStrength
Axatilimab9 mg/.18mL, 22 mg/2.2mL, 9 mg/.9mL, 22 mg/.44mL

What Niktimvo is used for

Niktimvo is a specialist medicine (colony stimulating factor-1 receptor blocker). Its approved uses are listed on the official FDA label below.

Key facts

Brand
Niktimvo
Generic name
Axatilimab-csfr
Made by
Incyte Corporation
Forms
Injection
Given
Intravenous
Drug class
Colony Stimulating Factor-1 Receptor Blocker
FDA approval
Biologic licence (BLA) BLA761411
On the US market since
2025

Official information

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Niktimvo?

Niktimvo (Axatilimab-csfr) is a specialist medicine made by Incyte Corporation, approved by the US FDA.

What are the ingredients of Niktimvo?

Niktimvo contains Axatilimab (9 mg/.18mL, 22 mg/2.2mL, 9 mg/.9mL, 22 mg/.44mL).

From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.

← All specialty medicines, USA

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.